SEARCH

SEARCH BY CITATION

References

  • Asanuma K., Ma Y., Okulski J., Dhawan V., Chaly T., Carbon M., Bressman S. B. and Eidelberg D. (2007) Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation. Neurology 64, 347349.
  • Augood S. J., Martin D. M., Ozelius L. J., Breakfield X. O., Penney J. B. and Standaert D. G. (1999) Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain. Ann. Neurol. 46, 761769.
  • Augood S. J., Hollingsworth Z., Albers D. S., Yang L., Leung J., Breakefield X. O. and Standaert D. G. (2004) Dopamine transmission in DYT1 dystonia. Adv. Neurol. 94, 5360.
  • Balcioglu A., Zhang K. and Tarazi F. I. (2003) Dopamine depletion abolishes apomorphine and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats. A microdialysis study. Neuroscience 119, 10451053.
  • Balcioglu A., Kim M. O., Sharma N., Cha J. H., Breakefield X. O. and Standaert D. G. (2007) Dopamine release impaired in a mouse model of DYT1 dystonia. J. Neurochem. 102, 783788.
  • Chefer V. I., Czyzyk T., Bolan E. A., Moron J., Pintar J. E. and Shippenberg T. S. (2005) Endogenous κ-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. J. Neurosci. 25, 50295037.
  • Dang M. T., Yokoi F., McNaught K. S. P., Jengelley T. A., Jackson T., Li J. and Li Y. (2005) Generation and characterization of Dyt1 ΔGAG knock-in mouse as a model for early-onset dystonia. Exp. Neurol. 196, 452463.
  • Dang M. T., Yokoi F., Pence M. A. and Li Y. (2006) Motor deficits and hyperactivity in Dyt1 knockdown mice. Neurosci. Res. 56, 470474.
  • Ellgaard L. and Helenius A. (2003) Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 4, 181191.
  • Farhan H., Freissmuth M. and Sitte H. H. (2006) Oligomerization of neurotransmitter transporters: a ticket from the endoplasmic reticulum to the plasma membrane. Handb. Exp. Pharmacol. 175, 233249.
  • Franklin K. B. and Paxinos G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, Burlington, MA.
  • Giros B., Jaber M., Jones S. R., Wrightman R. M. and Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606612.
  • Goodchild R. E., Kim C. E. and Dauer W. T. (2005) Loss of the dystonia associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 48, 923932.
  • Grundmann K., Reischmann B., Vanhoutte G., et al. (2007) Overexpression of human wild-type torsinA and human ΔGAG torsinA in a transgenic mouse model causes phenotypic abnormalities. Neurobiol. Dis. 27, 190206.
  • Hewett J., Gonzalez-Agosti C., Slater D., Ziefer P., Li S., Bergeron D., Jacoby D. J., Ozelius L. J., Ramesh V. and Breakefield X. O. (2000) Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells. Hum. Mol. Genet. 9, 14031413.
  • Hewett J. W., Tannous B., Niland B. P., Nery F. C., Zeng J., Li Y. and Breakefield X. O. (2007) Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells. Proc. Natl Acad. Sci. USA 104, 72717276.
  • Ichinose H., Ohye T., Takahashi E. et al. (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat. Genet. 8, 236242.
  • Jankovic J. and Fahn S. (1993) Dystonic disorders, in Parkinson’s Disease and Movement Disorders (JankovicJ. and TolosaE., eds), pp. 337374. Williams and Wilkins, Baltimore, MD.
  • Jones S. R., Garris P. A. and Wightman R. M. (1995) Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens. J. Pharmacol. Exp. Ther. 274, 396403.
  • Jones S. R., Gainetdinov R. R., Wightman R. M. and Caron M. G. (1998a) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 19791986.
  • Jones S. R., Gainetdinov R. R., Jaber M., Giros B., Wightman R. M. and Caron M. G. (1998b) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc. Natl Acad. Sci. USA 95, 40294034.
  • Justice J. B. (1993) Quantitative microdialysis of neurotransmitters. J. Neurosci. Methods 48, 263276.
  • Knappskog P. M., Flatmark T., Mallet J., Ludecke B. and Bartholome K. (1995) Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 4, 12091212.
  • Koh Y. H., Rehfeld K. and Ganetzky B. (2004) A Drosophila model of early onset torsion dystonia suggests impairment in TGF-beta signaling. Hum. Mol. Genet. 13, 20192030.
  • Kuczenski R. and Segal D. S. (1992) Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmacol. Exp. Ther. 262, 10851094.
  • Kuczenski R., Segal D. S., Cho A. K. and Melega W. (1995) Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J. Neurosci. 15, 13081317.
  • Kustedjo K., Bracey M. H. and Cravatt B. F. (2000) Torsin A and its torsion dystonia-associated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations. J. Biol. Chem. 275, 2793327939.
  • Liu Z., Zolkiewska A. and Zolkiewska M. (2003) Characterization of human torsinA and its dystonia-associated mutant form. Biochem. J. 374, 117122.
  • Lupas A., Flanagan J. M., Tamura T. and Baumeister W. (1997) Self-compartmentalization proteases. Trends Biochem. Sci. 22, 399404.
  • McNaught K. S., Kapustin A., Jackson T., Jengelley T. A., Jnobaptiste R., Shashidharan P., Perl D. P., Pasik P. and Olanow C. W. (2004) Brainstem pathology in DYT1 primary torsion dystonia. Ann. Neurol. 56, 540547.
  • Misbahuddin A., Placzek M. R., Taanman J. W., Gschmeissner S., Schiavo G., Cooper J. M. and Warner T. T. (2005) Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells. Mov. Disord. 20, 432440.
  • Morón J. A., Brockington A., Wise R. A., Rocha B. A. and Hope B. T. (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J. Neurosci. 22, 389395.
  • Neuwald A. F., Aravind L., Spouge J. L. and Koonin E. V. (1999) AAA+: a class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res. 9, 2743.
  • Ogura T. and Wilkinson A. J. (2001) AAA+ superfamily ATPases: common structure – diverse function. Genes Cells 6, 575597.
  • Orset C., Parrot S., Sauvinet V., Cottet-Emard J. M., Bérod A., Pequignot J. M. and Denoroy L. (2005) Dopamine transporters are involved in the onset of hypoxia-induced dopamine efflux in striatum as revealed by in vivo microdialysis. Neurochem. Int. 46, 623633.
  • Ozelius L. J., Hewett J., Page C. et al. (1997) The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat. Genet. 17, 4048.
  • Piazza P. V., Deminiere J. M., Le Moal M. and Simon H. (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science 245, 15111513.
  • Piazza P. V., Deminiere M. S., Le Moal M. and Simon H. (1990) Individual reactivity to novelty predicts probability of amphetamine self-administration. Behav. Pharmacol. 1, 339345.
  • Piazza P. V., Rouge-Pont F., Deroche V., Maccari S., Simon H. and Le Moal M. (1996) Glucocorticoids have state-dependent stimulant effects on the mecencephalic dopaminergic transmission. Proc. Natl Acad. Sci. USA 93, 87168720.
  • Pisani A., Martella G., Tscherter A., Bonsi P., Sharma N., Bernardi G. and Standaert D. G. (2006) Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Neurobiol. Dis. 24, 318325.
  • Placzek M. R., Misbahuddin A., Chaudhuri K. R., Wood N. W., Bhatia K. P. and Warner T. T. (2001) Cervical dystonia is associated with a polymorphism in the dopamine (D5) receptor gene. J. Neurol. Neurosurg. Psychiatry 71, 262264.
  • Rauge-Pont F., Usiello A., Benoit-Marand M., Gonon F., Piazza P. V. and Borrelli E. (2002) Changes in extracellular dopamine-induced by morphine and cocaine: crucial control by D2 receptors. J. Neurosci. 22, 32933301.
  • Rostasy K., Augood S. J., Hewett J. W., Leung J. C., Sasaki H., Ozelius L. J., Ramesh V., Standaert D. G., Breakefield X. O. and Hedreen J. C. (2003) TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol. Dis. 12, 1124.
  • Rouge-Pont F., Deroche V., LeMoal M. and Piazza P. V. (1998) Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur. J. Neurosci. 10, 39033907.
  • Rupniak N. M., Jenner P. and Marsden C. D. (1986) Acute dystonia unduced by neuroleptic drugs. Psychopharmacology 88, 403419.
  • Sharma N., Baxter M. G., Petravicz J., Bragg C. D., Schienda A., Standaert D. G. and Breakefield X. O. (2005) Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J. Neurosci. 25, 53515355.
  • Shashidharan P., Sandu D., Potla U., Armata I. A., Walker R. H., McNaught K. S., Weisz D., Sreenath T., Brin M. F. and Olanow C. W. (2005) Transgenic mouse model of early-onset DYT1 dystonia. Hum. Mol. Genet. 14, 125133.
  • Strome E. M., Cepeda I. L., Sossi V. and Doudet D. J. (2006) Evaluation of the dopamine system in a rodent model of Parkinson’s disease: small animal positron emission tomography compared to behavioral assessment and autoradiography. Mol. Imaging. Biol. 8, 292299.
  • Sulzer D., Sonders M. S., Poulsen N. W. and Galli A. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406433.
  • Torres G. E., Sweeney A. L., Beaulieu J. M., Shashidharan P. and Caron M. G. (2004) Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated ΔE-torsinA mutant. Proc. Natl Acad. Sci. USA 101, 1565015655.
  • Wichmann T. (2008) Dopaminergic dysfunction in DYT1 dystonia. Exp. Neurol. 212, 242246.
  • Williams J. M. and Galli A. (2006) The dopamine transporter: a vigilant border control for psychostimulant action. Handb. Exp. Pharmacol. 175, 215232.
  • Zhao Y., DeCuypere M. and LeDoux M. S. (2008) Abnormal motor function and dopamine neurotransmission in DYT1 deltaGAG transgenic mice. Exp. Neurol. 210, 719730.